Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Proud

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Plos One|July 19, 2012
Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genesDavid Proud, Magdalena H Hudy, Shahina Wiehler, et al.
American Journal of Respiratory and Critical Care Medicine|July 29, 2008
Gene expression profiles during in vivo human rhinovirus infection: insights into the host responseDavid Proud, Ronald B Turner, Birgit Winther, et al.
Nature|June 5, 2020
IGF1R is an entry receptor for respiratory syncytial virusCameron D Griffiths, Leanne M Bilawchuk, John E McDonough, et al.
Nature|June 20, 2020
Publisher Correction: IGF1R is an entry receptor for respiratory syncytial virusCameron D Griffiths, Leanne M Bilawchuk, John E McDonough, et al.
Thorax|July 25, 2013
British Thoracic Society guideline on pulmonary rehabilitation in adultsCharlotte E Bolton, Elaine F Bevan-Smith, John D Blakey, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2017
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled studyPhilip E Silkoff, Susan Flavin, Robert Gordon, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Journal of Crohn'S & Colitis|May 12, 2023
DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-MakingMisha Kabir, Siwan Thomas-Gibson, Phil J Tozer, et al.
JAMA Surgery|June 30, 2021
Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review, Alexandra M Zaborowski, Ahmed Abdile, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Plos One|July 19, 2012
Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genesDavid Proud, Magdalena H Hudy, Shahina Wiehler, et al.
American Journal of Respiratory and Critical Care Medicine|July 29, 2008
Gene expression profiles during in vivo human rhinovirus infection: insights into the host responseDavid Proud, Ronald B Turner, Birgit Winther, et al.
Nature|June 5, 2020
IGF1R is an entry receptor for respiratory syncytial virusCameron D Griffiths, Leanne M Bilawchuk, John E McDonough, et al.
Nature|June 20, 2020
Publisher Correction: IGF1R is an entry receptor for respiratory syncytial virusCameron D Griffiths, Leanne M Bilawchuk, John E McDonough, et al.
Thorax|July 25, 2013
British Thoracic Society guideline on pulmonary rehabilitation in adultsCharlotte E Bolton, Elaine F Bevan-Smith, John D Blakey, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2017
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled studyPhilip E Silkoff, Susan Flavin, Robert Gordon, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Journal of Crohn'S & Colitis|May 12, 2023
DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-MakingMisha Kabir, Siwan Thomas-Gibson, Phil J Tozer, et al.
JAMA Surgery|June 30, 2021
Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review, Alexandra M Zaborowski, Ahmed Abdile, et al.
Pageof 10